Literature DB >> 33446212

Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis.

Liangshan Mu1, Xiaoting Sun2, Mixue Tu1, Dan Zhang3.   

Abstract

BACKGROUND: Genetic, environmental and epigenetical factors may play important roles in the pathogenesis of polycystic ovary syndrome (PCOS), however the etiology of PCOS remains unclear. Studies indicated that non-coding RNAs (ncRNAs) were involved in the occurrence and development of PCOS. Thus, we aim to perform a systematic review and meta-analysis to investigate the presence and dysregulated expression of ncRNAs in human PCOS.
METHODS: We searched in PubMed, Medline, Web of Science and Embase until July 2019 and summarized all eligible publications focusing on microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs) and small interfering RNAs (siRNAs) in PCOS.
RESULTS: Sixty-seven articles were included in our systematic review and 9 articles were included in meta-analysis. There is little overlap between studies when comparing miRNA profiles. Sensitivity analysis showed that the expression of miR-93 was upregulated in PCOS patients (WMD 0.75, P < 0.00001), without heterogeneity among remaining studies (I2 = 0%).
CONCLUSION: A large number of ncRNAs with altered levels were observed in plasma, serum, follicular fluid, granulosa cells or other issues from PCOS patients. Aberrant ncRNAs expression in PCOS may lead to aberrant steroidogenesis, adipocyte dysfunction, altered ovarian cell proliferation and/or apoptosis and have the potential to be used as diagnostic biomarkers.

Entities:  

Keywords:  Long non-coding RNA; Non-coding RNA; Polycystic ovary syndrome; circRNA; microRNA

Year:  2021        PMID: 33446212     DOI: 10.1186/s12958-020-00687-9

Source DB:  PubMed          Journal:  Reprod Biol Endocrinol        ISSN: 1477-7827            Impact factor:   5.211


  103 in total

Review 1.  microRNAs: tiny regulators with great potential.

Authors:  V Ambros
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

Review 2.  Genome regulation by long noncoding RNAs.

Authors:  John L Rinn; Howard Y Chang
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

Review 3.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

4.  Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Hector F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

Review 5.  Treatment strategies for women with polycystic ovary syndrome.

Authors:  Peipei Jin; Yongyong Xie
Journal:  Gynecol Endocrinol       Date:  2017-10-31       Impact factor: 2.260

Review 6.  The noncoding RNA revolution-trashing old rules to forge new ones.

Authors:  Thomas R Cech; Joan A Steitz
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

Review 7.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

8.  Prevalence of symptoms associated with polycystic ovary syndrome.

Authors:  Asa Lindholm; Liselott Andersson; Mats Eliasson; Marie Bixo; Inger Sundström-Poromaa
Journal:  Int J Gynaecol Obstet       Date:  2008-03-05       Impact factor: 3.561

Review 9.  Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome.

Authors:  Francesco Orio; Giovanna Muscogiuri; Cinar Nese; Stefano Palomba; Silvia Savastano; Domenico Tafuri; Giorgio Colarieti; Giovanbattista La Sala; Annamaria Colao; Bulent O Yildiz
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2016-08-12       Impact factor: 2.435

Review 10.  From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).

Authors:  Roberta Piva; Demetrios A Spandidos; Roberto Gambari
Journal:  Int J Oncol       Date:  2013-08-12       Impact factor: 5.650

View more
  12 in total

1.  Long non-coding RNA HLA-F antisense RNA 1 inhibits the maturation of microRNA-613 in polycystic ovary syndrome to promote ovarian granulosa cell proliferation and inhibit cell apoptosis.

Authors:  Xiaohua Li; Laifang Zhu; Yan Luo
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA (miR-27a, miR-196a2, miR-423) Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS.

Authors:  Rashid Mir; Nizar H Saeedi; Mohammed M Jalal; Malik A Altayar; Jameel Barnawi; Abdullah Hamadi; Faris J Tayeb; Sanad E Alshammari; Nabil Mtiraoui; Mohammed Eltigani M Ali; Faisel M Abuduhier; Mohammad Fahad Ullah
Journal:  J Pers Med       Date:  2022-04-06

3.  Involvement of ferroptosis in the granulosa cells proliferation of PCOS through the circRHBG/miR-515/SLC7A11 axis.

Authors:  Dan Zhang; Shuijing Yi; Bing Cai; Zengyan Wang; Minghui Chen; Zetong Zheng; Canquan Zhou
Journal:  Ann Transl Med       Date:  2021-08

4.  Circular RNA as a Potential Biomarker for Melanoma: A Systematic Review.

Authors:  Keyun Tang; Hanlin Zhang; Yaqi Li; Qiuning Sun; Hongzhong Jin
Journal:  Front Cell Dev Biol       Date:  2021-04-01

5.  Circular RNA circ_RANBP9 exacerbates polycystic ovary syndrome via microRNA-136-5p/XIAP axis.

Authors:  Xiaohui Lu; Haijie Gao; Bo Zhu; Guilan Lin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting BMPR1A in polycystic ovary syndrome.

Authors:  Yuanyuan Zhao; Shuhong Pan; Yunying Li; Xiaohua Wu
Journal:  Sci Rep       Date:  2022-03-14       Impact factor: 4.996

7.  The circular RNA circ_0030018/miR-136/migration and invasion enhancer 1 (MIEN1) axis promotes the progression of polycystic ovary syndrome.

Authors:  Jing Xu; Qinghua Qu; Bao Liu; Liyuan Shen
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

8.  Long non-coding RNA-X-inactive specific transcript inhibits cell viability, and induces apoptosis through the microRNA-30c-5p/Bcl2-like protein 11 signaling axis in human granulosa-like tumor cells.

Authors:  Yichuan Guo; Xueping Peng; Ran Cheng; Hui Chen; Xiaoyan Luo
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

Review 9.  Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue.

Authors:  Agata Wawrzkiewicz-Jałowiecka; Anna Lalik; Graça Soveral
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

10.  Biochemical Characterization and Molecular Determination of Estrogen Receptor-α (ESR1 PvuII-rs2234693 T&gt;C) and MiRNA-146a (rs2910164 C&gt;G) Polymorphic Gene Variations and Their Association with the Risk of Polycystic Ovary Syndrome.

Authors:  Rashid Mir; Faris J Tayeb; Jameel Barnawi; Mohammed M Jalal; Nizar H Saeedi; Abdullah Hamadi; Malik A Altayar; Sanad E Alshammari; Nabil Mtiraoui; Mohammed Eltigani Ali; Faisel M Abu Duhier; Mohammad Fahad Ullah
Journal:  Int J Environ Res Public Health       Date:  2022-03-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.